Literature DB >> 32380206

Strategies to bioengineer aptamer-driven nanovehicles as exceptional molecular tools for targeted therapeutics: A review.

Ramesh Thevendran1, Shigdar Sarah2, Thean-Hock Tang3, Marimuthu Citartan4.   

Abstract

Aptamers are a class of folded nucleic acid strands capable of binding to different target molecules with high affinity and selectivity. Over the years, they have gained a substantial amount of interest as promising molecular tools for numerous medical applications, particularly in targeted therapeutics. However, only the different treatment approaches and current developments of aptamer-drug therapies have been discussed so far, ignoring the crucial technical and functional aspects of constructing a therapeutically effective aptamer-driven drug delivery system that translates to improved in-vivo performance. Hence, this paper provides a comprehensive review of the strategies used to improve the therapeutic performance of aptamer-guided delivery systems. We focus on the different functional features such as drug deployment, payload capacity, in-vivo stability and targeting efficiency to further our knowledge in enhancing the cell-specific delivery of aptamer-drug conjugates. Each reported strategy is critically discussed to emphasize both the benefits provided in comparison with other similar techniques and to outline their potential drawbacks with respect to the molecular properties of the aptamers, the drug and the system to be designed. The molecular architecture and design considerations for an efficient aptamer-based delivery system are also briefly elaborated.
Copyright © 2020 Elsevier B.V. All rights reserved.

Keywords:  Aptamer-based drug delivery system; Aptamer-drug conjugate; Functional aspects; Strategies; Targeted therapeutics

Mesh:

Substances:

Year:  2020        PMID: 32380206     DOI: 10.1016/j.jconrel.2020.04.051

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  4 in total

Review 1.  Novel Strategies to Combat Bacterial Biofilms.

Authors:  Fatemeh Hemmati; Mohammad Ahangarzadeh Rezaee; Saba Ebrahimzadeh; Leila Yousefi; Roghayeh Nouri; Hossein Samadi Kafil; Pourya Gholizadeh
Journal:  Mol Biotechnol       Date:  2021-04-29       Impact factor: 2.695

Review 2.  Advances in Exosome-Based Drug Delivery and Tumor Targeting: From Tissue Distribution to Intracellular Fate.

Authors:  Juntang Shao; Jennica Zaro; Yuxian Shen
Journal:  Int J Nanomedicine       Date:  2020-11-24

Review 3.  Development and application of ribonucleic acid therapy strategies against COVID-19.

Authors:  Lin Ning; Mujiexin Liu; Yushu Gou; Yue Yang; Bifang He; Jian Huang
Journal:  Int J Biol Sci       Date:  2022-08-01       Impact factor: 10.750

4.  Antibiotic administration in targeted nanoparticles protects the faecal microbiota of mice.

Authors:  Baris A Borsa; Mert Sudagidan; Mehmet E Aldag; Isik I Baris; Elif E Acar; Cagatay Acuner; Murat Kavruk; Veli C Ozalp
Journal:  RSC Med Chem       Date:  2021-01-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.